Enteric Disease Testing Market Growth, Outlook, Scope, Trends and Opportunity 2024-2032 from stanley huds's blog

Global Enteric Disease Testing Market Statistics: USD 5.5 Billion Value by 2032

Summary:

• The global enteric disease testing market size reached USD 4.2 Billion in 2023.
• The market is expected to reach USD 5.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.1% during 2024–2032.
• Asia Pacific leads the market, accounting for the largest enteric disease testing market share.
• Based on the product type, the market has been bifurcated into reagents and consumables and equipment.
• Molecular diagnostics hold the largest share in the enteric disease testing industry.
• Bacterial enteric disease (C. difficile, Campylobacteriosis, Cholera, E. coli, H. pylori, Salmonellosis, and Shigellosis) represents the leading disease type segment.
• On the basis of the end user, the market has been classified into hospital diagnostic laboratories, independent diagnostic laboratories, academic and research institutes, and others.
• The growing focus on preventive healthcare is a primary driver of the enteric disease testing market.
• The rise of point-of-care (POC) testing solutions and the increasing public awareness and education are reshaping the enteric disease testing market.

Industry Trends and Drivers:

● Growing focus on preventive healthcare:

Governing bodies and healthcare organizations are emphasizing early detection and intervention strategies to mitigate the spread of infectious diseases. Regular screening and diagnostic testing for enteric diseases, especially in at-risk populations, are being promoted as essential public health measures. This shift from reactive to preventive approaches aims to reduce the burden on healthcare systems by catching infections before they develop into larger outbreaks. In countries with advanced healthcare infrastructure, preventive testing is becoming a routine part of public health programs, particularly for food safety, water quality monitoring, and sanitation practices. The rising awareness about the importance of early diagnosis in controlling the spread of enteric diseases is catalyzing the demand for testing services.

● Rise of point-of-care (POC) testing solutions:

The increasing demand for point-of-care (POC) testing solutions represents one of the key factors impelling the market growth. These portable, user-friendly diagnostic tools allow for rapid testing near patients or in remote settings, reducing the time required for results and facilitating faster treatment decisions. POC diagnostics are particularly important in low-resource environments where access to central laboratories may be limited. The ease of use, coupled with the reduced need for specialized training to operate these devices, makes POC testing an attractive option in both developed and developing regions. The growing cases of enteric diseases are driving the need for fast, on-the-spot testing solutions. In addition to healthcare facilities, these tests are being deployed in areas like food production and water quality monitoring, ensuring broader market applications.

● Increasing public awareness and education:

Growing public awareness about the risks of enteric diseases and the importance of hygiene is driving the need for more comprehensive and accessible testing solutions. Governments and health organizations are increasing their efforts to educate the public on how enteric diseases spread, their symptoms, and the importance of timely testing and treatment. Mass media campaigns, educational programs in schools, and community outreach initiatives are raising awareness about the importance of clean water, proper sanitation, and food safety, especially in regions prone to frequent outbreaks. The rising demand for reliable diagnostic testing is a direct result of these educational efforts, as individuals become more proactive in seeking testing when symptoms of enteric diseases arise.

Request for a sample copy of this report: https://www.imarcgroup.com/enteric-disease-testing-market/requestsample

Enteric Disease Testing Market Report Segmentation:

Breakup By Product Type:

• Reagents and Consumables
• Equipment

Based on the product type, the market has been bifurcated into reagents and consumables and equipment.

Breakup By Technology:

• Molecular Diagnostics
• Immunodiagnostics

Molecular diagnostics exhibit a clear dominance in the market attributed to its high accuracy and speed in detecting enteric pathogens.

Breakup By Disease Type:

• Bacterial Enteric Disease
• C. Difficile
• Campylobacteriosis
• Cholera
• E. Coli
• H. Pylori
• Salmonellosis
• Shigellosis
• Viral Enteric Disease
• Rotavirus
• Norovirus
• Others
• Parasitic Enteric Disease
• Amebiasis
• Cryptosporidiosis
• Giardiasis

Bacterial enteric disease (C. difficile, Campylobacteriosis, Cholera, E. coli, H. pylori, Salmonellosis, and Shigellosis) represents the largest segment, as bacterial infections are the most common cause of enteric diseases worldwide.

Breakup By End User:

• Hospital Diagnostic Laboratories
• Independent Diagnostic Laboratories
• Academic and Research Institutes
• Others

On the basis of the end user, the market has been classified into hospital diagnostic laboratories, independent diagnostic laboratories, academic and research institutes, and others.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Asia Pacific dominates the market owing to a high prevalence of enteric diseases among the population and increasing investment in healthcare infrastructure.

Top Enteric Disease Testing Market Leaders:

The enteric disease testing market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Abbott Laboratories
• BD (Becton, Dickinson and Company)
• Bio-Rad Laboratories Inc.
• Biomerica Inc.
• Biomérieux SA
• Cepheid Inc. (Danaher Corporation)
• Coris BioConcept
• DiaSorin
• Meridian Bioscience Inc.
• Quest Diagnostics

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145